[ Price : $8.95]
FDA grants breakthrough therapy designation to Lillys oloromasib for certain lung cancers.[ Price : $8.95]
FDA releases the form FDA-483 containing 14 observations from an inspection at the GenoGenix outsourcing facility in Boca Raton, F...[ Price : $8.95]
Sanofi says its investigational antibody amlitelimab met all primary and key secondary endpoints in a late-stage trial of patients...[ Price : $8.95]
Bipartisan criticism of Health and Human Services secretary Robert F. Kennedy Jr. dominates a contentious three-hour Senate Financ...[ Price : $8.95]
FDA releases 89 previously unpublished complete response letters and says future letters will be released immediately after transm...[ Price : $8.95]
Medtronic Perfusion Systems recalls (Class 1) its DLP Left Heart Vent Catheters (malleable body and vented connector) because the ...[ Price : $8.95]
FDA posts a drug complex innovative design case study for a higher dose of an alopecia areata drug that did not assign participant...[ Price : $8.95]
FDA says an advisory committee is not needed to discuss the Aquestive NDA for Anaphylm to treat severe allergic reactions.